TR201821116A2 - POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ - Google Patents

POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ Download PDF

Info

Publication number
TR201821116A2
TR201821116A2 TR2018/21116A TR201821116A TR201821116A2 TR 201821116 A2 TR201821116 A2 TR 201821116A2 TR 2018/21116 A TR2018/21116 A TR 2018/21116A TR 201821116 A TR201821116 A TR 201821116A TR 201821116 A2 TR201821116 A2 TR 201821116A2
Authority
TR
Turkey
Prior art keywords
posaconazol
manufacturing
pharmaceutical compositions
compositions containing
composition
Prior art date
Application number
TR2018/21116A
Other languages
English (en)
Inventor
Kurt Bülent
Kumar Dude Udaya
Original Assignee
Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi
Publication of TR201821116A2 publication Critical patent/TR201821116A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, Posakonazol ve farmasötik açıdan kabul edilebilir yardımcı maddelerin farmasötik bileşimi ve bu bileşimin üretim yöntemi ile ilgilidir.
TR2018/21116A 2016-12-31 2018-12-30 POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ TR201821116A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2016/20462A TR201620462A2 (tr) 2016-12-31 2016-12-31 POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ

Publications (1)

Publication Number Publication Date
TR201821116A2 true TR201821116A2 (tr) 2019-07-22

Family

ID=60888079

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2016/20462A TR201620462A2 (tr) 2016-12-31 2016-12-31 POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR2018/21116A TR201821116A2 (tr) 2016-12-31 2018-12-30 POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2016/20462A TR201620462A2 (tr) 2016-12-31 2016-12-31 POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ

Country Status (4)

Country Link
EP (1) EP3342399B1 (tr)
ES (1) ES2927852T3 (tr)
HR (1) HRP20221127T1 (tr)
TR (2) TR201620462A2 (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201722493A2 (tr) * 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
WO2020159562A1 (en) 2019-01-29 2020-08-06 Slayback Pharma Llc Pharmaceutical compositions of posaconazole
WO2022034232A1 (en) 2020-08-13 2022-02-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
CN112641756B (zh) * 2020-12-29 2022-08-19 卓和药业集团股份有限公司 一种泊沙康唑肠溶微丸及其制备方法
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
WO2023012378A1 (en) 2021-11-25 2023-02-09 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole
WO2024041662A1 (zh) * 2023-09-18 2024-02-29 北京德立福瑞医药科技有限公司 泊沙康唑固体分散体及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4520281A1 (es) 1993-12-21 1997-10-15 Schering Corp Antifungicos de tetrahidrofurano
ZA974428B (en) 1996-05-24 1997-11-24 Schering Corp Antifungal composition with enhanced bioavailability.
ATE273002T1 (de) 1996-06-28 2004-08-15 Schering Corp Feste lösung eines fungizids mit erhöhter bioverfügbarkeit
AU759982B2 (en) 1997-10-07 2003-05-01 Merck Sharp & Dohme Corp. Crystalline antifungal polymorph
JP5124267B2 (ja) * 2005-02-25 2013-01-23 武田薬品工業株式会社 顆粒の製造方法
JP2009538927A (ja) 2006-05-30 2009-11-12 エラン ファーマ インターナショナル，リミティド ナノ粒子状のポサコナゾール製剤
CN102065842A (zh) 2008-04-15 2011-05-18 先灵公司 优选含有泊沙康唑和hpmcas的固体分散体形式的口服药物组合物
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2861213A1 (en) 2012-06-14 2015-04-22 Sandoz AG Pharmaceutical composition comprising crystalline posaconazole
ITMI20132114A1 (it) 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
US20150231081A1 (en) 2014-02-20 2015-08-20 Cadila Healthcare Limited Delayed release posaconazole tablets
WO2017025292A1 (en) * 2015-08-08 2017-02-16 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant formulation containing posaconazole
EP3210599A1 (en) * 2016-02-26 2017-08-30 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
WO2017032908A1 (en) * 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole

Also Published As

Publication number Publication date
ES2927852T3 (es) 2022-11-11
EP3342399B1 (en) 2022-08-31
TR201620462A2 (tr) 2018-07-23
HRP20221127T1 (hr) 2022-12-09
EP3342399A1 (en) 2018-07-04

Similar Documents

Publication Publication Date Title
TR201821116A2 (tr) POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
CY1123845T1 (el) Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων
EA201890126A1 (ru) Новые бициклические производные, способ их получения и фармацевтические композиции, содержащие их
EA201892838A1 (ru) Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их
EA201891622A1 (ru) Новые производные аммония, способ их получения и фармацевтические композиции, содержащие их
MX2019001313A (es) Composiciones farmaceuticas.
MX2019002057A (es) Formas solidas de mesilato de cenicriviroc y procesos para elaborar formas sólidas de mesilato de cenicriviroc.
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201790650A1 (ru) Лекарственная форма и способы применения абиратерона ацетата
EA202090098A1 (ru) Фармацевтические композиции терапевтически активных соединений
MX2017014035A (es) Formas solidas novedosas.
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
IN2013MU03583A (tr)
MX2018008424A (es) Compuestos antiproliferativos y sus composiciones farmaceuticas y usos.
MY186047A (en) Eutectic formulations of cyclobenzaprine hydrochloride
MX2017016619A (es) Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos.
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
MX2019005855A (es) Formulaciones que se pueden pulverizar.
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
EA201791600A1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
CL2019001053A1 (es) Formulaciones farmacéuticas y métodos para prepararlas.
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
EA201890364A1 (ru) СОЕДИНЕНИЯ, ПРИГОДНЫЕ ДЛЯ ИНГИБИРОВАНИЯ ROR-ГАММА-t
IN2014CH00840A (tr)
EA201700356A1 (ru) Новые циклопропанбензофуранилпиридопиразиндионы